Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | DRD2 | P14416 | 1/20 | 1.00 |
| ▸ | PTGES | O14684 | 9/20 | 0.86 |
| ▸ | ALOX5 | P09917 | 8/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.82 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.63 |
| ▸ | CDK2 | P24941 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | AURKA | O14965 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lonazolac SCHEMBL287156 | 0.99 | KDM4E (0.97) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| Lonazolac SCHEMBL1478078 | 0.99 | KDM4E (0.97) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| SCHEMBL11245260 | 0.95 | KDM4E (0.90) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| SCHEMBL11166545 | 0.94 | KDM4E (0.90) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| SCHEMBL10877279 | 0.91 | KDM4E (0.83) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| SCHEMBL10407060 | 0.90 | KDM4E (1.00) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| SCHEMBL12608902 | 0.90 | KDM4E (0.81) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| SCHEMBL3475488 | 0.90 | KDM4E (0.81) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| Lonazolac SCHEMBL10577835 | 0.88 | PTGES (1.00) | KDM4EDRD2PTGESALOX5ALDH1A1 | |
| SCHEMBL11258042 | 0.88 | KDM4E (0.79) | KDM4EDRD2PTGESALOX5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5295 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| US-20260000741-A1 | METHOD OF AMELIORATING A PRO-INFLAMMATORY IMMUNOPHENOTYPE IN FARBER DISEASE SUBJECTS BY REPEATED ADMINISTRATION OF A RECOMBINANT HUMAN ACID CERAMIDASE | ACERAGEN INC (US) | 2026-01-01 | — | — | US | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| US-20250041208-A1 | NEW INJECTABLE COMBINATION FORMULATION | NANEXA AB (SE) | 2025-02-06 | — | — | US | claimed |
| EP-4470565-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | OnQuality Pharmaceuticals China Ltd. (CN) | 2024-12-04 | — | — | EP | claimed |
| US-RE50218-E1 | Non-steroidal anti-inflammatory ophthalmic compositions | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2024-11-26 | — | — | US | claimed |
| EP-4444277-A1 | NEW INJECTABLE COMBINATION FORMULATION | Nanexa AB (SE) | 2024-10-16 | — | — | EP | claimed |
| CN-118742325-A | Methods for preventing or treating diseases or conditions associated with antineoplastic agents | 上海岸阔医药科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| EP-0374602-A1 | Lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1990-06-27 | — | — | EP | claimed |
| US-4914121-A | CURING IMMUNITY DISEASES AND NEPHROPATHY | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1990-04-03 | — | — | US | claimed |
| EP-0336147-A2 | Diethylene glycol monoesters, process for their preparation and their use as medicines | Merckle GmbH (DE) | 1989-10-11 | — | — | EP | claimed |
| EP-0335164-A2 | Ester derivatives of neopentanol, process for their preparation and their use as medicines | Merckle GmbH (DE) | 1989-10-04 | — | — | EP | claimed |
| WO-1989008119-A1 | HIGH MOLECULAR WEIGHT PRODRUG DERIVATIVES OF ANTI-INFLAMMATORY DRUGS | SELCH LARSEN CLAUS (DK) | 1989-09-08 | — | — | WO | claimed |
| EP-0331471-A1 | High molecular weight prodrug derivatives of antiinflammatory drugs | Larsen, Claus Selch (DK) | 1989-09-06 | — | — | EP | claimed |
| EP-0299504-A1 | A process for the preparation of 1-phenyl-3-(4-chlorophenyl)-pyrazol-4-ylacetic acid and its calcium salt | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu (CS) | 1989-01-18 | — | — | EP | claimed |
| EP-0272704-A2 | Use of pyrazole derivatives in the treatment of immunity diseases and nephropathy | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1988-06-29 | — | — | EP | claimed |
| US-4325962-A | ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIDYRETICS | BYK-GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1982-04-20 | — | — | US | claimed |
| US-4146721-A | ANALGESICS, ANTIINFLAMMATORY AGENTS AND ANTIPYRETICS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1979-03-27 | — | — | US | claimed |